Fortress Biotech
New York
About Fortress Biotech
Fortress Biotech is a biopharmaceutical company focusing on acquiring, developing, and commercializing high-potential marketed and development-stage drugs and drug candidates. Fortress has 5 marketed products and over 25 programs in development through its majority-owned and majority-controlled partners and partners it founded and holds significant minority ownership positions. Target therapeutic areas and technologies include oncology, rare diseases, gene and cell therapy, and other areas of high unmet need.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 101 – 250
- Estimated revenue: $50K – $100K
- Total funding: $204.8M
- Funding stage: IPO
- Last round: Post-IPO Equity (Sep 2024)
- Ticker: nasdaq:FBIO
- Website: fortressbiotech.com
- Phone: 212-574-2800
Industries & Categories
Biotechnology, Health Care, Life Science, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/fortress-biotech-41244 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.